The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60. Health ...

Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...

The most powerful public health official in the US is reviled by some medics - but even some of his critics accept that he is ...

Bird flu continues to spread quickly through the U.S. farm system because that system is inherently a viral playground.

Chemists welcome plans for NHS patients to access weight-loss jabs but warn it will need sufficient funding ...

The Trump administration’s new vaccine advisers endorsed this fall's flu vaccines late last week, but only those that don't ...

Stanley Black & Decker has designated Christopher Nelson to succeed Donald Allan Jr. as president and chief executive of the tool maker, effective Oct. 1. Financial services companies like BNY and ...

The trial readout comes at a time of turbulence in the vaccine sector after RFK Jr replaced every member of the ACIP panel.

A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...

Moderna's mRNA flu vaccine showed 26.6% better efficacy than a standard flu shot in adults 50 and older during a global Phase ...

The latest phase 3 win is a boost for Moderna’s attempts to create a flu/COVID combination vaccine. The company withdrew a filing for FDA approval for its combo candidate last month while it waited ...

Due to the ongoing U.S. measles outbreak, a Texas man worried that his young son was at risk and took him to get vaccinated.